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Abstract
Background: Single-cell genomic methods now provide unprecedented resolution for characterizing the component
cell types and states of tissues such as the epithelial subsets of the gastrointestinal tract. Nevertheless, functional studies
of these subsets at scale require faithful in vitro models of identified in vivo biology. While intestinal organoids have
been invaluable in providing mechanistic insights in vitro, the extent to which organoid-derived cell types recapitulate
their in vivo counterparts remains formally untested, with no systematic approach for improving model fidelity.
Results: Here, we present a generally applicable framework that utilizes massively parallel single-cell RNA-seq to
compare cell types and states found in vivo to those of in vitro models such as organoids. Furthermore, we leverage
identified discrepancies to improve model fidelity. Using the Paneth cell (PC), which supports the stem cell niche and
produces the largest diversity of antimicrobials in the small intestine, as an exemplar, we uncover fundamental gene
expression differences in lineage-defining genes between in vivo PCs and those of the current in vitro organoid model.
With this information, we nominate a molecular intervention to rationally improve the physiological fidelity of our in
vitro PCs. We then perform transcriptomic, cytometric, morphologic and proteomic characterization, and demonstrate
functional (antimicrobial activity, niche support) improvements in PC physiology.
Conclusions: Our systematic approach provides a simple workflow for identifying the limitations of in vitro models and
enhancing their physiological fidelity. Using adult stem cell-derived PCs within intestinal organoids as a model system,
we successfully benchmark organoid representation, relative to that in vivo, of a specialized cell type and use this
comparison to generate a functionally improved in vitro PC population. We predict that the generation of
rationally improved cellular models will facilitate mechanistic exploration of specific disease-associated genes
in their respective cell types.
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Background
Intestinal organoids, derived from intestinal stem cells
(ISCs) and composed of ISCs, Paneth cells (PCs), enter-
oendocrine cells (EECs), goblet cells, and absorptive
enterocytes, have been invaluable to the study of intes-
tinal biology [1]. Recent advances in massively parallel
single-cell RNA-sequencing (scRNA-seq) [2] have en-
abled the cataloging of cell types and states of the
murine small intestinal epithelium [3] and intestinal
organoids [4], offering extensive insight into tissue het-
erogeneity, specifically within subsets of rare secretory
cell populations. However, there have been no formal
comparisons of how the in vitro intestinal organoid
condition recapitulates the defined in vivo cell types.
While the generation of comprehensive cellular atlases
has become a major focus of a global effort to map
tissues in humans, model organisms, and derived
organoids at single-cell resolution [5], the challenge of
how to functionally investigate key insights from cell
types in vivo, or even more simply to confirm the
high-fidelity representation of these states in existing
model systems remains [6, 7].
Intestinal organoids are a compelling system with
which to study specialized cells of the epithelium. They
are self-organizing, stem cell-derived structures, which,
to a reasonable degree, resemble their in vivo counter-
part, can be rapidly grown, and are amenable to many
biochemical and genetic perturbations [8]. Recent work
has demonstrated the utility of organoids in assessing
bulk phenotypes that are readily observed and easily
selected for, such as phenotypes of cystic fibrosis and the
study of cancer-associated mutational signatures [9, 10].
However, the application of organoid models to the study
of complex disease, such as polygenic inflammatory
disease, has been limited. In such instances, the subtler
phenotypes, such as those present in inflammatory bowel
disease (IBD), may not manifest if the originating cell state
present in vivo is not accurately represented within an
organoid model. This challenge is particularly clear in IBD
[11], where loci identified through genome wide associ-
ation studies (GWAS) have proven difficult to efficiently
examine through the use of in vivo animal models.
For instance, PC dysfunction is implicated in Crohn’s
disease, a subset of IBD typically afflicting the small bowel
[12]. Co-localized with LGR5+ ISCs of the small intestinal
crypts, long-lived PCs [13] support maintenance of the
ISC niche, producing the Wnt and Notch signaling ligands
WNT3 and DLL4 [14], and are potent modulators of the
gut microflora through secretion of multiple antimicro-
bials including lysozyme (LYZ), phospholipase A2 group
1B (PLA2G1B), angiogenin ribonuclease A family member
5 (ANG5), and alpha-defensins (DEFAs), amongst others
[15]. Multiple allelic variants of NOD2, ATG16L1, and
XBP1, are associated with ileal Crohn’s disease [16–19]
and have been identified in animal models to cause clear
PC phenotypes, including lower DEFA expression [20],
defects in autophagy, granule formation, and secretion
[19, 21], and uncompensated ER stress [22]. While in vivo
models currently provide the most physiologically repre-
sentative system to probe PC biology, they are inherently
complex and poorly scaled, hindering basic research into
molecular mechanisms of disease and the potential for
scalable therapeutic screening. Recently, conventional
intestinal organoids were used to describe the dynamics of
PC degranulation in response to multiple agonists [23]
and to assess PC suppression of enteric pathogens [24].
While these organoid studies are arguably more repre-
sentative than other in vitro systems, the question of
physiological fidelity of this heterogeneous system re-
mains unanswered, especially given that the timescales
to derive conventional organoids is typically less than a
week, while in vivo the lifespan of a PC is on the order
of several weeks.
To improve the representation of specific cell types in
intestinal organoids, investigators have utilized cellular
engineering approaches starting with ISCs to derive
multiple enriched or specialized models. These include
enterocytes with improved intestinal ion transport [25],
epithelial monolayers capable of secretion and IgA
transcytosis [26], and organoids enriched for the rare
secretory EEC population [27]. However, in each in-
stance, there has been no global comparison of the
extent to which intestinal organoids, or further special-
ized derivatives, recapitulate defined in vivo cell types
and states. Moving beyond the generation of in vivo
tissue maps towards mechanistic insights, particularly in
disease settings, will require an understanding of how
the in vitro organoid models utilized for such studies
represent the cell types and states identified beyond
single marker genes.
Here, we provide a global comparison between the in
vivo cell states of the murine small intestinal epithelium
and the in vitro conventional intestinal organoid, and
establish a systematic workflow for improving the physio-
logical representation of stem cell-derived cell states to
enable the creation of high-fidelity in vitro models. Taking
the PC as a test case, we utilize massively parallel single-cell
transcriptomics (scRNA-seq; Seq-Well) [28] to bench-
mark the conventional organoid model against its in vivo
counterpart and identify differences in developmental
pathway signaling between in vitro and in vivo cell states.
Single-cell transcriptomic approaches were key in enab-
ling this study as epithelial cell types are challenging to re-
liably and prospectively isolate by fluorescence-activated
cell sorting (FACS) due to the absence of robust surface
markers and the spectrum of differentiation states present.
This profiling guides the rational augmentation of signal-
ing pathway activity during stem cell differentiation with a
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small molecule chemical induction method we previously
validated to enhance global Lyz gene expression [29]. We
validate our approach by generating an enhanced in vitro
physiological mimic of the in vivo PC and provide a
detailed characterization of the derived cell state through
morphologic, proteomic, transcriptomic, and functional
assays based on known signatures of in vivo PCs. Further-
more, we use our enhanced model and findings from its
transcriptomic and proteomic characterization to identify
Nupr1 as a potential stress-response factor that facilitates
the survival of PCs, demonstrating the improved ability
to examine gene function in vitro within a more repre-
sentative cell type.
Results
Using the PC to benchmark cell type representation of
conventional organoids against their in vivo counterparts
Conventional intestinal organoids produced from the
spontaneous differentiation of ISCs have been used to
study PCs in vitro in multiple contexts [23, 24]. These in
vitro PCs exist as part of a heterogeneous system, yet to
be rigorously benchmarked against their in vivo counter-
parts. To better understand the composition of PCs
within conventional organoids and how well those PCs
approximate their in vivo counterparts, we sought to
globally compare the conventional organoid-derived PCs
and their in vivo counterparts through a single-cell tran-
scriptomic approach (Fig. 1a).
To relate the organoid-derived PC state to in vivo PCs,
we first generated an unbiased reference in vivo scRNA-seq
data set. We performed massively parallel scRNA-seq using
the recently developed Seq-Well platform [28] on epithelial
cells from the ileal region of the small intestine acquired as
two biological replicates (see Methods). We assessed quality
metrics for the number of genes, unique molecular identi-
fiers (UMIs), mitochondrial genes, and ribosomal genes, all
of which fell within expectations (all cells average: 1043
genes, 2168 UMIs, 5.4% ribosomal genes, 10.4% mito-
chondrial genes). UMI-collapsed cell-by-gene (7667
cells × 17,505 genes) expression matrices were analyzed
using Seurat (see Methods), performing dimensionality
reduction, graph-based clustering, and deriving lists of
cluster-specific genes in order to identify PCs. Within
the spectrum of cell types, we identified two clusters (2
and 11) enriched for Lyz1 expression (Fig. 1b, c), of
which we determined cluster 11 to be fully mature PCs
(n = 189 cells) based on uniform expression of a set of
associated antimicrobial peptide marker genes such as
Defa22, Defa21, and Ang4 (receiver operating charac-
teristic (ROC) test, area under the curve (AUC) > 0.99
for markers listed; cluster 11 average: 866 genes, 3357
UMI, 3.5% ribosomal genes, 4.8% mitochondrial genes)
(Additional file 1: Table S1). We further utilized these
genes (genes with AUC > 0.65 for in vivo PC) throughout
our study to relate organoid-derived cell states to in vivo
PCs. They are fully inclusive of the 14 high confidence
markers described for Paneth cells from the terminal
ileum in the recently published mouse small intestinal
atlas [3]. Of note, we extended our gene list beyond truly
specific marker genes that are not expressed in other cell
types as we were interested in a more comprehensive set
of PC-enriched genes for further comparison.
We next performed scRNA-seq using Seq-Well on
conventional organoids derived from a single donor
ISC-enriched state (Fig. 1a). Beginning with murine small
intestinal crypts, we directly enriched for LGR5+ ISCs
over 6 days following isolation within a Matrigel scaffold
and medium containing recombinant growth factors EGF
(E), Noggin (N), and R-spondin 1 (R), small molecules
CHIR99021 (C), and valproic acid (V), as well as Y-27632
for the first 2 days to inhibit rho kinase and mitigate
anoikis, as previously described (ENR+CV) [29]. To
ensure reproducibility within our system and limit the risk
of interference in our chemical induction approach, we
conducted our study exclusively with recombinant growth
factors and not cell line-derived conditioned media. Cells
were passaged into conventional ENR culture for an
additional 6 days to allow multi-lineage differentiation
and produce stem cell-derived in vitro PCs. Following
scRNA-seq, we computationally identified six clusters
(amongst 2513 cells × 16,198 genes meeting quality
standards, see Methods) in ENR organoids, which we
label as ENR1-4, and EEC-1 and -2 for two EEC
types (Fig. 1d). We identified ENR-4 as the cluster
most enriched for Lyz1 and our PC reference gene set
(effect size 0.721, ENR-4 vs. all ENR, *t test p < 2.2 ×
10−16; for effect size details see Methods) (Fig. 1e, f ).
Having identified ENR-4 as the cell state of interest
in organoids, we directly compared the top 200 most
PC-like cells in ENR-4 to in vivo PCs by performing
differential expression analysis (Fig. 1g). In comparing
the two cell types, it became evident that the majority of
genes enriched by in vivo PCs were defensins and antimi-
crobials, including Defa22, Defa21, Zg16, Ang4, Defa3,
and Lyz1 (all p < 2.92 × 10−37, bimodal test, Bonferroni
corrected for multiple comparisons) (Fig. 1g, h). ENR-4
cells were enriched for Chgb, an enteroendocrine
marker, and translational biosynthetic genes likely
indicative of the high rates of proliferation present
in ENR organoids (Fig. 1g). We further note the
difference in genes arising from non-sex matched
comparison, like Xist, as a limitation of our compari-
son between a single donor for organoid derivation.
Beyond these selected genes, we note a global reduc-
tion in the fraction of the transcriptome of ENR-4
cells producing the total cadre of in vivo PC marker
genes (effect size 1.25, InVivo vs. ENR, *t test p <
2.2 × 10−16), suggesting that the current in vitro
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organoid-derived PCs are suboptimal for physio-
logical studies (Fig. 1i).
Modulating key developmental pathways of stem
cell-derived systems has emerged as a paradigm in
bioengineering to rationally generate cell types for basic
research and therapeutic aims [30, 31]. Specifically, modu-
lating Wnt and Notch signaling has been suggested in the
literature to increase the frequency and magnitude of Lyz1
expression and protein in ISC-derived cells [29, 32–34].
Leveraging the single-cell transcriptomes of our in
vitro- and in vivo-derived PCs, we confirmed that
Wnt target genes are enriched in vivo relative to in
vitro PCs (effect size 0.559, InVivo vs. ENR, *t test
p < 2.035 × 10−8) and Notch target genes were decreased
(effect size −0.500, InVivo vs. ENR, *t test p < 5.25 × 10−7)
(Fig. 1i, Additional file 2: Table S2). As a result, we sought
to comprehensively test if driving Wnt and inhibiting
Notch truly results in a more physiologically representa-
tive PC versus the organoid-derived PC, beyond bulk mea-
sures of increased Lyz1 expression.
Rationally guided chemical induction of Wnt and
inhibition of Notch drives PC marker enrichment
Beginning with an LGR5+ ISC-enriched population (ENR
+CV), we sought to profile how the modulation of Wnt
and Notch signaling through small molecule inhibitors
would alter the in vitro PC state, as suggested by our
transcriptional profiling. We performed chemical induction
(CI) using the previously identified compounds C to drive
Wnt signaling and DAPT (D), a gamma-secretase inhibitor,
to inhibit Notch (ENR+CD) (Fig. 2a) and measured bulk
gene expression of PC (Lyz1, Defa1, Mmp7) and ISC (Lgr5)
markers every 2 days for a total of 6 days (Fig. 2b). ENR
+CD-treated cells had statistically significant increases
in Lyz1 (adj. p = 0.005, see Methods) and Mmp7 (adj.
p = 0.005) within 2 days compared to ENR, with differ-
ences plateauing around 4 days. Defa1 (adj. p = 0.004)
expression was significantly increased by day 4 and
plateaued by day 6 in ENR+CD versus ENR popula-
tions. Lgr5 expression in ENR+CD at 2 days versus
ENR showed an insignificant plateau of expression,
which trended down by 6 days. This may be indicative
of an expansion in ‘label-retaining’ secretory precur-
sors [35]. The precursor population ENR + CV had no
significant difference in PC or ISC markers relative to
ENR. The significant increase in PC gene expression
in ENR + CD relative to ENR and ENR+CV over the
6-day treatment suggests rapid enrichment following
CI, supporting our hypothesis that alterations in Wnt
and Notch result in superior PC enrichment in vitro.
To phenotypically describe PC enrichment following
CI, we performed imaging and immunocytochemistry
for PC-associated features. After 6 days of ENR + CD,
cell populations exhibited darkened annular morphology
consistent with increased numbers of granule-rich cells
(Additional file 3: Figure S1A). Confocal microscopy of
whole cell clusters stained for anti-DEFA and anti-LYZ
showed an increase in LYZ+ and DEFA+ cells in ENR +
CD compared to both ENR and ENR + CV (Fig. 2c).
Single-cell counting of confocal imaging showed a
significant increase of DEFA and LYZ co-staining cells
in ENR + CD (20–30% of cells) versus either ENR or
ENR + CV (both < 5%; adj. p = 0.0001) (Additional file 3:
Figure S1B). Additionally, normalized z-axis profiles of in-
dividual co-staining cells within cell clusters revealed a con-
sistent distribution of DEFA (luminally polarized) and LYZ
(diffuse) (Additional file 3: Figure S1C 1–3). High-resolution
fluorescent imaging of individual co-staining cells from
freshly isolated small intestinal crypts (in vivo equivalent)
and 6-day ENR + CD-treated cells showed a similar
polarized distribution of LYZ- and DEFA-stained gran-
ules, although freshly isolated cells appeared to be
more granular than CI-PCs (Fig. 2d).
To confirm the extent of enrichment seen in whole
population imaging, the prevalence of PCs in ENR + CD
relative to ENR was assessed by flow cytometry over the
(See figure on previous page.)
Fig. 1 Transcriptional benchmarking of in vitro Paneth cells (PCs) to in vivo. a Schematic of intestinal epithelial cell isolation from terminal ileum for
unbiased identification of in vivo PC signature genes, and system for intestinal stem cell (ISC) enrichment to characterize in vitro PCs, via high-throughput
scRNA-seq. b Marker gene overlay for binned count-based expression level (log(scaled UMI + 1)) of Lyz1, a canonical PC marker gene, on a
tSNE (t-stochastic neighbor embedding) plot of 7667 small intestinal epithelial cells isolated from the terminal ileum; receiver operating
characteristic (ROC)-test area under the curve (AUC) = 0.995, n = 2 mice, independent experiments (Additional file 1: Table S1). c Violin plot
for the count-based expression level (log(scaled UMI + 1)) of Lyz1 across clusters identified through shared nearest neighbor (SNN) analysis
(see Methods) over small intestinal epithelial cells; n = 196 cells in cluster 11, 7667 cells in total. d A tSNE plot of 2513 cells, with clusters
identified through SNN (Additional file 1: Table S1 for full gene lists with ROC-test AUC > 0.60) from conventional ENR organoids; n = 6
wells of ENR organoids. e Marker gene overlay for binned count-based expression level (log(scaled UMI + 1)) of Lyz1 on a tSNE plot from; ROC-test
AUC = 0.856. f Violin plot of expression contribution to a cell’s transcriptome of PC genes across ENR organoid clusters from (d) (In vivo PC gene list
AUC > 0.65, Additional file 1: Table S1); effect size 0.721, ENR-4 vs. all ENR, *t test p < 2.2 × 10−16. g Row-normalized heatmap of top differentially
expressed genes using bimodal test over single-cells from the top 200 PC-like cells from ENR-4 and the 196 in vivo PCs (cluster 11, from (c)); *bimodal
test, all displayed genes p < 1.89 × 10−16 or less with Bonferroni correction. h Violin plots for the count-based expression level (log(scaled UMI + 1)) of
Lyz1, Ang4, and Defa3 in ENR and in vivo PCs; *bimodal test, all p < 2.92 × 10−37 or less with Bonferroni correction. i Violin plot of expression contribution
to a cell’s transcriptome of PC genes (effect size 1.25, InVivo vs. ENR, *t test p < 2.2 × 10−16), Wnt pathway (effect size 0.559, InVivo vs. ENR, *t test
p < 2.035 × 10−8) and Notch pathway (effect size −0.500, InVivo vs. ENR, *t test p < 5.25 × 10−7) genes (see Additional file 2: Table S2 for gene lists)
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course of 12 days, a longer term culture than typical for
conventional organoids. We identified an in vivo PC
phenotype as CD24 and LYZ co-positive cells, as per
previous reports [36], and noted the presence of
single-positive LYZ+ or single-positive CD24+ popula-
tions, indicative of alternative cell differentiation, imma-
ture, or non-physiological PCs (representative populations
Additional file 3: Figure S1D, representative gating
Additional file 3: Figure S1E). ENR +CD had substantial
enrichment at all time points for double-positive, and
single-positive LYZ+ or CD24+ populations relative to
ENR, as well as a consistent decrease in the double
negative population in agreement with the PC phenotype
(Fig. 2e). Notably, both ENR and ENR +CD experience
declines in total cell viability, with ENR + CD having
greater survival at longer times, suggesting both a reduc-
tion in anoikis, a potentially physiological ‘long-lived’ PC
phenotype in ENR + CD versus ENR, or an enhance-
ment in niche-supporting functionality (Additional
file 3: Figure S1F). Overall, imaging and flow cytometry
demonstrate a significant increase in cells morphologically
resembling in vivo PCs with respect to granularity, polar-
ity, and antimicrobial co-expression in ENR +CD com-
pared to conventional ENR organoids (Fig. 2c–e and
Additional file 3: Figure S1A–F).
Chemically induced PC proteome is enriched for
components of secretory lineages
With ENR + CD apparently providing a more prevalent
and physiological PC population, we sought to more
globally characterize the differences between in vitro
PCs (ENR vs. ENR + CD) at 6 days. Because our single
cell transcriptomic comparison revealed that many of
the differential genes between PCs in conventional orga-
noids and in vivo were lineage-defining protein prod-
ucts, we sought to assess the total intracellular proteome
between the conventional organoid and our chemically
induced model through liquid chromatography mass
spectrometry (LC-MS/MS)-based proteomics. We quan-
tified relative protein abundance using isobaric mass
tag labeling from four ENR and four ENR + CD
samples and analyzed them in a single 10-plex by
LC-MS/MS (Additional file 4: Figure S2A). We identi-
fied 8015 unique proteins within all samples; each
replicate pair (ENR+CD/ENR) was normally distributed
(not shown) and correlated with all others, indicating con-
sistent proteome enrichment (Additional file 4: Figure S2B).
We looked at the sample pairs in aggregate and classified
proteins significantly enriched in ENR+CD and ENR by a
false discovery rate (FDR) < 0.05 and log fold change (± 2σ)
(Fig. 2f and Additional file 5: Table S3). There were 249
ENR +CD-enriched proteins, 212 ENR-enriched proteins,
and 7553 shared proteins. Known PC markers, including
LYZ, DEFAs, and other secretory pathway components,
were identified as significantly enriched in ENR+CD ver-
sus ENR alone. Of known antimicrobial proteins produced
by PCs, we detected 10 DEFAs, 5 CRS peptides, 6 ribonu-
cleases, 12 lectins, LYZ1, and PLA2G1B with differential
abundance between ENR+CD and ENR (Fig. 2g). Each
class of antimicrobials had at least one ENR+CD enriched
protein (+ 2σ), with the ribonucleases significantly enriched
and a majority of the lectins and DEFAs unregulated be-
tween the two conditions. Proteins associated with the EEC
lineage (secretogranins, chromogranins, and neuropeptides)
were also enriched in ENR+CD, in addition to multiple
other secreted components, including Wnt ligands, and the
complement pathway components C3 and CFI (Fig. 2h). In
sum, we see a broad diversity of PC-associated antimicro-
bials with some enrichment of EEC-associated proteins in
ENR +CD relative to ENR.
Additionally, we characterized enriched biological func-
tions, cellular compartments, and molecular functions
using DAVID v6.8 and the gene ontology database. All
sets had high database coverage (greater than 85%) of
queried proteins. The ENR + CD proteome is signifi-
cantly enriched for extracellular and protein process-
ing compartments and secretory-associated functions
(Additional file 4: Figure S2C), while the ENR prote-
ome favors translation, intracellular compartments,
and translational activities (Additional file 4: Figure
S2D). Of note, there are the extracellular exosome and
calcium ion-binding associated proteins in the ENR +
(See figure on previous page.)
Fig. 2 Establishing chemically induced Paneth cell (PC)-enriched cultures. a Schematic of small molecule-driven differentiation of LGR5+ ISCs
(C - CHIR99021, D - DAPT) and non-specific differentiation. b mRNA expression of PC (Lyz1, Defa1, Mmp7) and ISC (Lgr5) markers relative to ENR,
for ENR+CV and ENR + CD at 2 (D2), 4 (D4), and 6 days (D6) (n = 3 biological replicates; two-way ANOVA with multiple comparison test vs. ENR; **
adj. p < 0.01, *** adj. p < 0.001). c Representative confocal imaging of whole cell clusters for PC antimicrobials following 6 days in ENR+CD versus
ENR and ENR+CV: stained for anti-DEFA, anti-LYZ and counterstained with DAPI and for actin (phalloidin). d High-resolution fluorescent imaging
of in vivo and in vitro single cells from 6-day culture in ENR + CD shows similar morphology and antimicrobial expression: stained for DEFA and
LYZ, and counterstained with DAPI and for actin (phalloidin). e Viable cell populations from ENR, ENR+CD, and ENR+CV precursor culture have
distinct populations based on CD24 and LYZ content, indicative of PC maturity (n = 3 biological replicates; ENR + CV, days 4, 6, 12, n = 2 biological
replicates day 8). f Volcano plot of differentially regulated proteins between 6-day (6D) ENR + CD and ENR cells shows clear enrichment in secreted
and PC-associated proteins (labeled). Cut-offs are 2 standard deviations outside the mean expression level of the set and FDR < 0.05. g Rank-order log
fold change of detected PC antimicrobial proteins and between 6-day ENR + CD and ENR cultures (n = 4). h Rank-order log fold change of detected
secretory proteins associated with EEC and goblet lineages in ENR + CD relative to ENR cultures (n = 4)
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CD proteome that are indicative of the intestinal
epithelial secretory phenotype (for a complete list of
DAVID enrichments, refer to Additional file 6: Table
S4). These functional enrichments further support the
notion that the ENR + CD-cultured organoids are
enriched in secretory cells, including PCs, although it
does not rule out potential co-enrichment for the EEC
lineage. Finally, we sought to identify transcription
factors (TFs) that may mediate PC-specific differenti-
ation using GSEA [37, 38] with the MSigDB transcrip-
tion factor target (v5.2) gene set database [39] with a
moderately conservative cutoff (see Methods). We
generated an enrichment map [40, 41] of several TF
targets significantly enriched in both the ENR + CD
and ENR proteomes. In ENR + CD, the nuclear recep-
tors for progesterone, aldosterone, and glucocorticoid,
as well as the cellular differentiation-implicated TAL1,
RP58, and NRSF, were significantly enriched. In ENR,
the primary known enrichment was for the cell cycle and
proliferation-related E2F TF family (Additional file 4:
Figure S2E). These potential TFs are consistent with
CI-PC treatment driving expected terminal differentiation
of specialized cells, as opposed to conventional organoid
culture, which supports a broad mix of intestinal epithelial
cells, including proliferating populations. Furthermore,
this analysis suggests potential targets, such as progester-
one, aldosterone, and glucocorticoid, to modulate the
differentiation programs of this secretory cell population
in future studies.
Single-cell RNA sequencing profiles heterogeneity of
chemically induced PCs, revealing subsets with improved
transcriptional similarity to in vivo
With the apparent co-enrichment of canonical PC and
EEC proteins in the ENR +CD proteome, we sought to
identify whether we produce a homogenous population of
mixed-lineage secretory cells or a spectrum of unique cell
states between EEC and PC. We performed scRNA-seq
using the Seq-Well platform on cells from ENR+CD and
the precursor ENR +CV conditions to analyze alongside
conventional ENR organoids. To ensure experimental
robustness, we assessed quality metrics for the number of
genes, UMIs, mitochondrial genes, and ribosomal genes by
cluster, all of which fell within expectation (Additional file 7:
Figure S3). UMI-collapsed digital gene expression matrices
were analyzed using Seurat (see Methods), and displaying
all three treatments (ENR +CV, ENR, ENR +CD) in tSNE
space demonstrated clear separation between each condi-
tion (Fig. 3a), illustrating that the unique transcriptional
differences induced by each treatment were conserved
across all cells. Plotting key genes demonstrated that, as
expected, all cells expressed high levels of Epcam, that
ENR +CV cells had enhanced Mki67, a marker of prolifer-
ation, that the ENR +CD condition led to enrichment of
cells expressing antimicrobial Lyz1, Defa24, Defa3, Mmp7,
and EEC marker Chga, and that ENR enriched for absorp-
tive marker Fabp2-expressing cells (Fig. 3b).
To assess subpopulation structure and provide a
more robust measure of composition beyond canon-
ical marker genes, we performed unsupervised KNN
graph-based clustering on the captured cells (Fig. 3c, d
and Additional file 1: Table S1 for full gene lists),
distinguishing four clusters in each treatment condi-
tion. We then scored individual clusters according to
the amount of the transcriptome within each cell dedi-
cated to synthesizing the respective enriched proteins
from the bulk proteome data. We observed that ENR
+ CD clusters yield a significant enrichment for those
proteins detected in the up-regulated proteome (effect
size 1.38 ENR + CD vs. ENR clusters, p < 2.2 × 10−16)
and that the down-regulated proteins were enriched in
the ENR and ENR + CV conditions (Fig. 3d, e and data
not shown). Intriguingly, at the level of clusters, the
upregulated proteome was not evenly distributed
across all cells in ENR + CD, but was most enriched in
cluster ENR + CD-4, which represented approximately
10% of ENR + CD cells (effect size 2.40 ENR + CD-4
vs. all cells, p < 2.2 × 10−16) (Fig. 3d, e).
To address ENR +CD composition and how it relates to
conventional organoids, we interrogated the expression of
Lyz1, Chga, and other selected genes across each cluster
(Fig. 4a). We noted that clusters ENR-4 and ENR +CD-4
shared expression of Lyz1, Defa24, Defa3, and Mmp7, yet
ENR +CD-4 cells produced significantly more of each
canonical PC gene (bimodal test, p < 6.80 × 10−74 for genes
listed, Bonferroni corrected for multiple comparisons).
Furthermore, both ENR-4 and ENR +CD-4 cells lacked
expression of EEC genes like Chga, which was observed in
the EEC-1 and EEC-2 clusters arising from mixed-grouping
of the sample, as well as in ENR+CD-2 and ENR +CD-3
(Fig. 4a). Altogether, this suggests that ENR + CD drives
PC differentiation while also inducing a secretory tran-
sition state (ENR + CD-2 and 3) expressing a mix of PC
and EEC marker genes (Additional file 1: Table S1 for
full gene lists).
We next sought to compare the states generated in
vitro to those observed in vivo with our refined system.
Using the gene list of in vivo PC markers and further de-
fining a list for in vivo EECs (see Methods) captured on
the Seq-Well platform (Additional file 1: Table S1), we
observed that the percentage of a cell’s transcriptome
dedicated to synthesizing defining Paneth genes was
significantly enriched relative to ENR-4 in clusters ENR
+ CD-2, -3, and -4 (effect size 0.15, p < 3.43 × 10−5; ef-
fect size 0.829, p < 2.2 × 10−16; effect size 2.52, p < 2.2 ×
10−16, respectively) with an increase in expression of
EEC genes across ENR + CD-1, -2, and -3 but not ENR
+ CD-4 (effect size 1.30, p < 2.2 × 10–16; effect size 1.82,
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p < 2.2 × 10–16; effect size 1.118, p < 2.2 × 10−16; effect size
0.0465, p = 0.2339, respectively) (Fig. 4b). Notably, ENR +
CD-4 cells (~10%) had a three-fold increase in the tran-
scriptional resemblance to in vivo PCs relative to ENR-4
(53.4% of transcriptome ENR +CD-4 vs. 16.5% of tran-
scriptome ENR-4) (quantification of Fig. 4b). Furthermore,
45% of ENR + CD cells express a secretory PC-like tran-
scriptional phenotype that is at least two-fold enhanced
relative to conventional organoids (33.9% of transcriptome
ENR +CD-3 and -4 vs. 16.5% ENR-4). Comparing the
ENR +CD-4 cells relative to in vivo PCs demonstrated a
striking similarity relative to the difference observed be-
tween in vivo and ENR-4 cells (PC fraction of in vivo
transcriptome: effect size 0.237 InVivo vs. ENR + CD-4,
p < 0.0055; effect size 1.25 InVivo vs. ENR-4, p < 2.2 ×
10−16 (Additional file 1: Table S1).
In Fig. 4c, we present a heatmap of scaled expression
values for the top genes (AUC > 0.65) used for the in
vivo Paneth score across ENR-4, ENR + CD-4, and the in
vivo cluster used to define PCs. We observed that the
a
c d e
b
Fig. 3 Single-cell RNA-sequencing reveals cellular composition across treatments and origins of proteomic data. a A tSNE plot of single cells derived
from ENR + CV (n= 985 cells), ENR (n= 2544 cells), and ENR + CD (n= 2382 cells) harvested at day 6 of differentiation, colored by treatment; n = 6 wells
for each condition. b Marker gene overlays (on plot from (a)) for binned count-based expression level (log(scaled UMI + 1)) of individual genes of interest.
c A tSNE plot, with clusters identified through SNN graph-based clustering (see Additional file 1: Table S1 for marker gene lists), highlighting distinct cell
states within each organoid; opacity of density clouds correspond to the Paneth cell score of ENR-4, ENR + CD-3, and ENR + CD-4 clusters (see Fig. 4b).
d Violin plot of expression contribution to a cell’s transcriptome of ENR + CD proteome-enriched genes across organoid clusters from (c) (see Additional
file 1: Table S1 for full gene list); effect size 2.40 ENR + CD-4 vs. all cells, p< 2.2 × 10−16. e Frequency of each cluster observed within each organoid
condition as a fraction of the total cells in each condition
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Fig. 4 (See legend on next page.)
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enhanced PC phenotype in ENR + CD-4 (effect size
1.144 ENR + CD-4 vs. ENR-4, p < 2.2 × 10−16) correlated
with a greater expression of signature genes, such as
Lyz1, Lyz2, and Defa5, and a greater diversity of anti-
microbial peptide genes, such as Ang4, Defa3, and the
metalloprotease Mmp7.
To confirm and extend our findings of pathway-based
modulation, we scored clusters for enrichment or depletion
of canonical growth factor-induced pathways. CHIR99021
activates the Wnt pathway, and we observed a significant
enrichment for Wnt target genes in all CI-PC clusters
(effect size > 0.999, p < 2.2 × 10−16 for all ENR +CD clus-
ters vs. ENR-4) (Additional file 8: Figure S4A). While
DAPT is a Notch pathway inhibitor, levels of Notch target
genes were largely greater than or equivalent to ENR-4
cells across CI-PC clusters, except for significant depletion
in ENR +CD-4 (effect size −0.658, p < 2.2 × 10−16 ENR +
CD-4 vs. ENR-4) (Additional file 8: Figure S4B). This
suggests that complete Notch suppression is key for PC
differentiation distinct from an EEC fate. Additionally,
given the recognized role for distinct respiratory potential
in enterocytes, ISCs, and PCs, we scored cells across
respiratory electron transport genes [42, 43]. ENR +CD-4
had the lowest cluster score relative to all cell subsets
(effect size −1.4649, p < 2.2 × 10–16) (Additional file 8:
Figure S4C). Together, this suggests that Wnt signaling
is necessary but not sufficient to specify the mature PC
phenotype and that Notch and metabolic conditions
play a larger role in the decision between PC and EEC
fates.
Chemically induced PCs mimic in vivo stimulant-induced
secretion and demonstrate selective modulation of
bacteria in co-culture
In addition to our morphological, proteomic, and tran-
scriptional characterization of PC phenotype in ENR +
CD and ENR, we sought to measure physiological
function by assessing stimulant-induced secretion of
antimicrobials. We assessed the dynamics of LYZ
accumulation in the supernatant media of cultures
following media wash, basally and after stimulation
with carbachol (CCh), a cholinergic agonist known to
induce PC secretion [44]. CCh (10 μM) induced a rapid
accumulation of LYZ within 2 hours that plateaued
around 6 hours post-wash (two-way ANOVA, stimulant
p < 0.0001, time-point p < 0.0001) (Fig. 5b). The ob-
served PC secretion in response to CCh is consistent
with observations made in ex vivo crypts, though over
appreciably longer time scales, likely due to the added
diffusion barrier of the organoid structure and matrigel
[44]. We next identified how LYZ secretion changes
over the course of differentiation. Beginning with an
ISC-enriched population, we assayed for secreted LYZ
in cell culture supernatants every 2 days for 6 days of
ENR + CD culture, following a 24-h stimulation with
CCh or without (basal collection/non-stimulated).
Notable increases in functional secretion (stimulated
relative to basal) occurred at days 4 and 6 (two-way
ANOVA, stimulant p < 0.0001, time-point p < 0.0001)
(Fig. 5a). Compared to conventional organoids and
ISC-enriched precursors, ENR + CD secreted significantly
more basal LYZ (p < 0.0001) and was the only population
that showed grossly measurable CCh-induced secretion
(adj. p = 0.03) (Fig. 5c). This result is consistent with the
observed enrichment between chemically induced popula-
tions relative to conventional.
Based on the broad spectrum of antimicrobials de-
tected proteomically, transcriptionally, and functionally,
we hypothesized that ENR + CD possess greater bacteri-
cidal effects than conventional organoids. We assayed
for bacterial growth modulation by suspending cell clus-
ters with common laboratory strains of gram-negative
and gram-positive bacteria in exponential growth.
CI-PCs significantly suppressed growth of gram-positive
L. lactis MG1363 (adj. p = 0.0001), which did not occur
with conventional organoids, indicative of increased
PC-associated antimicrobial activity (Fig. 5d). Both ENR
(adj. p = 0.0005) and ENR + CD (adj. p = 0.01) co-culture
showed significant increase in gram-negative E. coli
MG1655 growth but no appreciable effect was observed
on the growth of gram-positive E. faecalis V583 versus
bacteria alone (Fig. 5d). While this assay simplifies the
PCs’ physiological environment and may not be a direct
proxy for strain-specific growth modulation, it does
demonstrate that the PC-enrichment of ENR + CD ver-
sus conventional organoids enables detectable in vitro
bacteria species-specific PC antimicrobial response,
opening avenues for future experimentation.
(See figure on previous page.)
Fig. 4 Transcriptional identity of chemically induced Paneth cells (CI-PCs) within conditions and related to in vivo PCs. a Violin plots for the count-based
expression level (log(scaled UMI + 1)) of selected genes across called clusters, colors correspond to clusters in Fig. 4c; *t test, p < 6.80 × 10−74 or less with
Bonferroni correction, for Lyz1, Defa24, Defa3, and Mmp7 ENR + CD-4 relative to ENR-4. b Violin plot of expression contribution to a cell’s transcriptome of
in vivo PC and enteroendocrine marker-cell genes (see Additional file 1: Table S1 for full gene list, AUC > 0.65); effect size 2.52 ENR + CD-4 vs.
ENR-4, p < 2.2 × 10−16 for PC score; effect size 0.0465, p = 0.2339 ENR + CD-4 vs. ENR-4 for enteroendocrine cell score. c Row-clustered heatmap
of z-scores (−2.5 to 2.5; purple to yellow) for defining genes (n = 69 with AUC > 0.65 of in vivo PCs, see Additional file 1: Table S1 for full gene
list) across top 200 cells for PC score (Fig. 5b) from ENR-4 and ENR + CD-4 conditions compared to two biological replicates of in vivo PCs
from the terminal ileum (n = 196 cells)
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Chemically induced PCs provide niche support and
enhance conventional organoid survival
Beyond the generation of antimicrobial peptides, PCs
provide niche support for ISCs. We sought to test if
CI-PCs provided niche factors known to drive epithelial
regenerative turnover. We performed co-culture experi-
ments, mixing and re-plating cell populations derived
from 6 days of ENR or ENR + CD culture and assayed
co-culture viability, caspase activity, and cytotoxicity 24
and 48 h following re-plating in ENR media. If there was
no appreciable interaction, positive or negative, between
the two populations we would expect to see a linear
trend of every measured variable throughout mixing
ratios. However, we observe a significant positive inter-
action where the presence of both populations drives an
overall increase in cellular viability, beginning at 24 h
a
d e
b c
Fig. 5 Chemically induced Paneth cells (CI-PCs) are functional in response to host and microbial stimuli. a Supernatant LYZ from 24-h basal and
10 μm CCh-stimulated LYZ cells at varying number of days in ENR + CD culture (top). DNA content from matched samples (bottom) (n = 8 well
replicates; SEM error bars too small to visualize). b Supernatant LYZ from 6-day ENR + CD collected basally and following 10 μm CCh stimulation
for 0.5, 2, 4, 6, and 24 h (top). DNA content from matched samples basally and following 10 μm CCh stimulation (bottom) (n = 8 well replicates).
c 24-h basal (non-stimulated) and 10 μm CCh-stimulated LYZ secretion in 6-day ENR + CD versus ENR and ENR + CV (n = 8 well replicates; two-
way ANOVA with multiple comparison test; ns non-significant, * adj. p < 0.05, **** adj. p < 0.0001). d 4-h co-culture of freshly passaged 6-day ENR
and ENR + CD cells and select gram-negative and gram-positive aerobic bacteria (n = 13 well replicates; two-way ANOVA with multiple comparison
test, * adj. p < 0.05, *** adj. p < 0.001, **** adj. p < 0.0001). e Normalized cellular viability, caspase activity per viable cell, and cytotoxicity per viable cell
from 24-h and 48-h ENR and ENR + CD co-cultures at specified mixing ratios (n = 9 well replicates from three biological donors; one sample t test,*
p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001)
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(one-sample t test 1:1 p = 0.037) and increasing at 48 h
(one-sample t test 1:1 p = 0.001 and 1:3 p < 0.001)
(Fig. 5e). This is likely due to a significant decrease in
overall apoptosis relative to the total cell population
(one-sample t test 24 h 1:1 p = 0.004 and 1:3 p = 0.032,
48 h 1:3 p = 0.003), and unrelated to changes in cellular
cytotoxicity. We believe that the presence of a
PC-enriched population (from ENR + CD) is driving
this effect by providing increased soluble regenerative
factors to the ISC population in ENR organoids, in-
creasing the generation of new cells, and resulting in a
lower overall rate of apoptosis.
Mapping of in vivo PC-associated transcription factors to
in vitro proteome and transcriptome reveals Nupr1 as
important in epithelial survival
Finally, we sought to use this physiologically improved in
vitro PC system (ENR +CD) to identify novel factors po-
tentially supportive of PC survival or differentiation. Using
our in vivo PC and EEC gene lists, and filtering for only
TFs (using TFdb, downloaded September 2017) [45], we
identified a set of PC- or EEC-specific TFs. We mapped
these TFs to our in vitro proteome (Fig. 6a and Additional
file 5: Table S3), which revealed the previously unreported
NUPR1 as the most enriched PC-specific TF in ENR +
CD. This finding was supported by differential expression
between ENR +CD-2 (most EEC-like cells) and ENR +
CD-4 (p < 3.12 × 10−37, bimodal test, Bonferroni corrected
for multiple comparisons) (Fig. 6b). We further identified
Nupr1 in our in vivo PC populations, which showed spe-
cific and enriched expression of Nupr1 by in vivo PCs
(ROC test, AUC = 0.833) (Fig. 6b). Intriguingly, Nupr1 is a
stress-response gene, known to promote cellular survival
and senescence through mediation of autophagy, and has
primarily been studied in the context of cancer [46–48].
Autophagy and stress response have repeatedly been im-
plicated through GWAS study in PCs in IBD; however,
Nupr1 has only ever been reported in a single IBD GWAS
study, and its role in PC biology has not been formally in-
vestigated [49]. With our model, we sought to test the role
of NUPR1 on in vitro PC survival through the small
molecule inhibition of NUPR1 with trifluoperazine (TFP)
[50, 51]. While genetic perturbation may provide for more
specific effect measurement, we chose to use TFP as a
simple, albeit less specific, modulator, as the complexity
involved in selecting for a genetically perturbed popula-
tion of PCs in organoids, if Nupr1 is a survival gene, is be-
yond the scope of the present study. We first tested how
different dosages impact PC differentiation in combin-
ation with ENR +CD for 6 days, where doses above 1 μM
led to near total cell death, and where the few surviving
cells were primarily non-PC (Fig. 6c). This suggests that
Nupr1 is likely critical to cellular survival during the CI
differentiation process. We also tested the addition of TFP
for 2 days following a 6-day course of ENR + CD, where
again a profound, but not total, decline in cellular viability
was observed. Further, it appears that TFP treatment is se-
lectively more toxic to PC and PC-progenitor populations
relative to non-PC populations (Fig. 6d). In total, this ini-
tial investigation suggests that NUPR1 may be a critical
TF in PC development and survival, which carries
therapeutic implications which we will seek to validate
with expanded gene-perturbation studies in vitro and in
vivo in future work.
Discussion
We sought to directly compare a specific cell type present
in vivo to that derived in an intestinal organoid in vitro,
with the main goal of understanding the nature and extent
of divergence between the in vitro and in vivo conditions.
Empowered by recent advances in massively-parallel
scRNA-seq, we employed a generalizable approach to
define the relation between in vivo and organoid-derived
in vitro PCs and employ a rationally identified interven-
tion to improve in vitro representation through chemical
modulation of developmental pathways. Our scRNA-seq
approach enabled the identification of populations of
interest both in vivo and in vitro and the analysis of differ-
ences between subpopulations which would have other-
wise been greatly obscured in a bulk analysis of this
heterogeneous system. While others have recently used
scRNA-seq to profile the heterogeneity of intestinal orga-
noids [4] and the murine small intestinal epithelium [3],
we provide a direct comparison between the model and
system. This comparison is key to understanding what
complex models, such as intestinal organoids, really repre-
sent, how they may best be utilized and rational strategies
for improvement.
In our comparison, we identified that the PC-state of
conventional intestinal organoids poorly represents the
extent and breadth of antimicrobial gene expression, and
that modulation of Wnt and Notch during differentiation
may improve physiological representation. Using a com-
bination of small molecule promotion of Wnt and inhib-
ition of Notch signaling that had previously been shown to
improve the bulk expression of PC-marker gene Lyz1 [29],
we drove a secretory differentiation program and enriched
for mature PCs with greater diversity and expression of
antimicrobial peptides relative to existing in vitro models
and, thus, are more representative of in vivo PCs. Imaging
of this population revealed that they are positive for the
antimicrobials LYZ and DEFA, clearly polarized, and
granule rich, suggestive of a mature PC. This population is
approximately six-fold more abundant in ENR +CD than
an ENR organoid, as confirmed through image quantifica-
tion, flow cytometry and scRNA-seq. We further character-
ized the subpopulation enrichments of our ENR +CD
culture and directly compared it to conventional organoids.
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We identified two subpopulations in scRNA-seq (ENR +
CD-3 and ENR +CD-4) that account for approximately
half of the ENR +CD-treated cells with a high-degree of
transcriptional similarity to in vivo PCs, a greater percent-
age/matching than the ENR-subpopulation that most re-
sembles an in vivo PC (ENR-4). From this analysis, we
believe that in vitro PCs characterized in the past [23, 24]
likely represent secretory precursor populations lacking the
full phenotypic repertoire of the in vivo PC, which we
identify as the approximately 5% of single-staining LYZ+
cells present in ENR organoids as assessed by flow cytome-
try (Fig. 2e). This finding makes sense, given that conven-
tional organoid culture often occurs on the time scale of a
week, while in vivo PCs are relatively long lived (several
weeks), develop in non-sterile conditions, and presumably
would require longer periods of culture to reach maturity
in vitro. Indeed, our ENR +CD cultures show increasing
PC populations up to 12 days of culture and may likely
a b
c d
Fig. 6 CI-PCs reveal putative function of Nupr1 transcription factor in Paneth cell (PC) survival. a ENR + CD is enriched for in vivo PC and EEC
transcription factors, including Nupr1 (n = 4). b Violin plots for the count-based expression level (log(scaled UMI + 1)) of Nupr1 across in vivo and
in vitro called clusters. c Nupr1 inhibition with trifluorperazine (TFP) treatment concurrent with 6-day ENR + CD differentiation reveals dose-
dependent toxicity, with preference to PCs (CD24+ and LYZ+) and PC-like (CD24+ and LYZ+) populations as assessed by flow cytometry (n = 3
biological replicates). d 2-day TFP treatment following 6-day ENR + CD differentiation reveals dose-dependent toxicity, with preference to PCs
(CD24+ and LYZ+) and PC-like (CD24+ and LYZ+) populations as assessed by flow cytometry (n = 5 biological replicates)
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continue gaining at longer time points. While our ap-
proach moves us much closer to generating the in vivo PC
(fraction of in vivo transcriptome: effect size 0.237 InVivo
vs. ENR +CD-4, p < 0.0055; effect size 1.25 InVivo vs.
ENR, p < 2.2 × 10−16), we still do not capture the total
amount of antimicrobial peptides present in vivo, and
propose pathways to modulate in future studies.
Evidence suggests that PC antimicrobial expression
and function are influenced by genetic background [52]
and implicated in intestinal disease, including IBD [53].
How genetic background may influence differentiation
through this protocol is yet to be studied but especially
prudent, as we demonstrated the ability to detect a
broad spectrum of antimicrobial proteins and peptides
and their differential abundance within a PC-enriched
population. Interestingly, we identified that the same
subpopulation (ENR + CD-4) with the most transcrip-
tional overlap to our bulk ENR + CD-enriched proteome
also most closely resembles the in vivo PC. While this
subpopulation does not account for the majority of ENR
+ CD-cultured cells, it appears that ENR + CD-4 consist-
ently drives the PC phenotype in vitro. In addition to
assessing the role of genetic background or disease state
on antimicrobial content, our platform also affords the
ability to interrogate how alterations in protein process-
ing and storage in PCs affects the proteome, which has
been shown to drive shifts in the microbiome and may
be implicated in disease [54, 55]. Finally, while we
demonstrate an enriched phenotypic spectrum of anti-
microbials and Wnt ligands, we also identified several
neuropeptides and hormone products associated with
the EEC lineage within our system. Given that multiple
studies have linked the differentiation of PCs and EECs
through a common progenitor population [56], it is
reasonable to expect enrichment in one population
would also allow for some overlap with the other, as we
see in our scRNA-seq data. Future experiments will seek
to leverage these transition states to more formally iden-
tify genetic programs that underlie common or unique
developmental trajectories.
To understand how our chemical induction led to
distinct secretory subpopulations within the CI-PCs, we
mapped Wnt, Notch, and metabolic gene sets onto each
subpopulation. In our system, Notch-signature is highest
in the stem cells and EECs, lower in enterocytes, and
lowest in PCs. Our system’s Wnt signature is relatively
decreased in enterocytes (ENR largely) and increased in
PCs and EECs, both of which occur predominantly in the
Wnt-driven condition ENR +CD (CI-PCs). In total, this
suggests that Wnt is necessary for ISCs to commit to PC
and EEC lineages and that future experimentation with
specific synthetic Wnt ligands [57] may prove fruitful in
distinguishing Wnt target genes that discriminatorily yield
PCs or EECs. Additionally, it is clear that strong Notch
inhibition is important for mature PC development, pos-
sibly as a balance between differentiation and cell survival.
Interestingly, we also see a notable gradient in cellular
respiration across subpopulations, lowest in the PC and
highest in the stem cell and EEC lineages, in agreement
with recent work on the metabolic differences within the
stem cell niche [43], as another potential cue to further
specify PC differentiation. Future studies should incorpor-
ate temporal aspects to growth factor delivery akin to
what has been shown for degradable matrices [58] to
enhance purity and yield, and explore the role of meta-
bolic utilization in addition to growth factor signaling in
cellular fate determination. Indeed, while we implemented
an approach of chemical induction to drive model im-
provement, there are many other approaches which may
be implemented to seek similar shifts in the composition
of organoid systems, such as using novel ligands or tuning
of the material supports. Further, we appreciate that many
investigators have begun using R-spondin or Wnt condi-
tioned medias in their intestinal organoid cultures; how-
ever, to ensure consistency and control of the system
upon chemical induction we chose to use recombinant
growth factors in lieu of a less-characterized media prod-
uct, but this may not preclude their usage. Overall, our
analyses of single cell heterogeneity show that our sys-
tem is well positioned to further investigate the effects
of both known and unknown physiological cues on PC
differentiation and function.
One of the most important features we established with
our CI-PCs was the ability to measure PC functional
enrichment through simple soluble assays. We demon-
strated sufficient functional enrichment in PCs such that
enzymatic activity assays can detect stimulant-induced
secretion of antimicrobials as well as the promotion of
the ISC niche. Moreover, microbe co-culture assays
with our enriched cells produce measurable and select-
ive microbial growth modulation not observed using
conventional organoids. Co-culture strains were chosen
to demonstrate proof of concept of selective antimicro-
bial action and assess functionality compared to con-
ventional organoids. Given the results showing selective
modulation of bacterial growth, we believe that our sys-
tem could serve as a tool to further probe host-microbe
interaction in vitro. Furthermore, it would allow for in-
vestigations of both microbial mechanisms that elicit
PC response (e.g., TLRs) and the properties of complex
mixtures of secreted components, including multiple
antimicrobial proteins.
Conclusions
The generation of comprehensive cellular atlases from
humans and model organisms will revolutionize our
understanding of complex tissues [3]. Intestinal orga-
noids have already proven their value in studying human
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and murine epithelial biology. However, to rigorously
test hypotheses of basic biological or disease mechanism,
it will be essential to have simple and reliable protocols
for the generation of specialized subsets of cells which
cannot be readily isolated from tissue. The representa-
tiveness of cell states present in organoids and the
specialized cell types present in vivo [3] is an outstand-
ing question with implications in mucosal immunology,
developmental biology, and translational medicine. Our
single-cell genomics approach provides compelling evi-
dence that organoid-derived cell populations must be
validated to ensure physiological relevance, and add-
itionally provides a rational framework for identifying
cell states and their potential upstream drivers to modu-
late cellular composition. This approach could enable ad-
vances beyond conventional organoid systems to provide
an enriched highly specialized cell population that recapit-
ulates important physiological functions of the intestinal
epithelium and could represent an improvement in in
vitro PC culture for the purposes of high-throughput
screening, the study of host-microbe interactions, bio-
engineering (e.g., precision gene editing), and the identifi-
cation of novel genetic candidates in PC function (e.g.,
Nupr1). With this framework, we illustrate the power and
importance of rigorously characterizing the specialized
cell types derived in organoids to those defined in ‘atlas-le-
vel’ surveys of the intestinal epithelium.
Methods
Mice for tissue isolation
Proximal small intestine was isolated from C57BL/6
mice of both sexes, aged between 3 and 6 months in all
experiments.
Bacteria strains
Cells were stored at –80 ºC and grown as follows. E. coli
strain MG1655 was grown overnight in LB. For experi-
ments, overnight cultures of MG1655 were resuspended
in M9 supplemented with 0.4% glucose and 0.2% CASa-
mino acids. L. lactis strain MG1363 was grown in M17
media supplemented with 0.5% glucose, and E. faecalis
strain V583 was grown in Brain Heart Infusion media.
Crypt culture, enrichment, and differentiation
Small intestinal crypts were cultured as previously de-
scribed [59]. Briefly, crypts were resuspended in basal
culture medium (Advanced DMEM/F12 with 2 mM
GlutaMAX and 10 mM HEPES; Thermo Fisher Scien-
tific) at a 1:1 ratio with Corning™ Matrigel™ Membrane
Matrix – GFR (Fisher Scientific) and plated at the center
of each well of 24-well plates. Following Matrigel
polymerization, 500 μL of small intestinal crypt culture
medium (basal media plus 100X N2 supplement, 50X B27
supplement; Life Technologies, 500X N-acetyl-L-cysteine;
Sigma-Aldrich) supplemented with growth factors EGF (E;
50 ng/mL, Life Technologies), Noggin (N; 100 ng/mL,
PeproTech), and R-spondin 1 (R; 500 ng/mL, PeproTech)
and small molecules CHIR99021 (C; 3 μM, LC Laborator-
ies) and valproic acid (V; 1 mM, Sigma-Aldrich) was added
to each well. ROCK inhibitor Y-27632 (Y; 10 μM, R&D
Systems) was added for the first 2 days of culture. Cells
were cultured at 37 °C with 5% CO2, and cell culture
medium was changed every other day. After 6 days of
culture, crypt organoids were isolated from Matrigel by
mechanical dissociation. Isolated organoids were resus-
pended in TrypLE Express (Life Tech) to dissociate into sin-
gle cells, then replated in Matrigel with ENR+CV+Y
media for 2 days. Cells were once again passaged, either
into freezing media (Life Tech) for cryopreservation or
replated at approximately 200 organoids per well (24-well
plate) for ISC-enriched organoid expansion. ISC-enriched
organoids were passaged or differentiated every 6 days in
the ENR+CV condition. To differentiate, cells were pas-
saged as previously described, and crypt culture medium
containing growth factors ENR only or ENR+CD (DAPT,
10 μM; Sigma-Aldrich) was added to each well.
RNA extraction and qRT-PCR
Organoids were isolated from Matrigel in 24-well plates
following culture as previously described, and pellets
were lysed in TRI reagent with RNA extracted according
to the manufacturer’s protocol (T9424, Sigma). Resulting
RNA pellets were dissolved in UltraPure water and
cDNA synthesis was performed using QuantiTect Re-
verse Transcription Kit (Qiagen). qPCR reactions were
performed using TaqMan Universal Master Mix II (no
UNG), pre-designed TaqMan probes (Additional file 9:
Table S5), and 50 ng of sample cDNA (LifeTech). Reac-
tions were performed using an Applied Biosystems
7900HT system. qPCR results were analyzed using RQ
manager 1.2 software to obtain CT values used for rela-
tive quantification to the housekeeping gene Hprt.
Confocal imaging of whole cell clusters
ISC-enriched cell clusters (ENR +CV) suspended in 40 μL
of Matrigel were seeded onto round coverslips inside a
24-well plate. Cells were treated with ENR +CD, ENR +
CV, or ENR as previously described. At day 6, organoids
were rinsed (PBS0 3X) and fixed on the coverslips by incu-
bating with 4% paraformaldehyde (PFA) for 30 min at
room temperature (RT). Gels were blocked and perme-
abilized by incubating at RT for 1 hour with 0.1% Triton
X-100 and 5% Powerblock in PBS0. Organoids were
stained for DEFA and LYZ by incubating with rat
anti-mouse Crp1 (Ayabe Lab clone 77-R63, 5 μg/mL, 50X)
and rabbit anti-human Lyz (Dako, RRID: AB_2341230,
200X) primary antibodies diluted to 10 μg/mL in staining
solution (0.1% Triton X-100 and 10X Powerblock in PBS0)
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overnight at 4 °C, followed by secondary antibodies Alexa
Fluor 647 anti-Rabbit IgG (RRID: AB_2563202, 400X) and
Alexa Fluor 488 anti-Rat IgG (RRID: AB_2563120, 400X)
diluted in staining solution for 1 h at RT. Actin was stained
with Alexa Fluor 555 Phalloidin (40X) for 20 min, followed
by staining of the nucleus with 3 μM DAPI for 5 min.
Coverslips were mounted onto slides with Vectashield and
imaged within 5 days using an Olympus FV2000 confocal
microscope. Whole organoid confocal microscopy images
were processed and analyzed using ImageJ. To determine
the PC purity percentage, the ImageJ Point Picker plugin
was used to count the number of nuclei to determine the
total number of cells and to count the number of DEFA-
and LYZ-containing PCs across all z-slices. To investigate
cell polarity in whole organoids, individual cells were
selected using ImageJ and mean area intensity within
selected cell areas was computed in each z-slice through-
out the depth of the image across every channel imaged.
High-resolution single-cell imaging
Cell clusters were harvested and rinsed (basal culture
media 3X) to remove Matrigel as previously described.
Isolated clusters were resuspended in TrypLE Express
and incubated at 37 °C for 20 min to dissociate into
single cells, then rinsed (basal culture media 2X) and
resuspended in PBS containing magnesium and calcium.
Pre-coated poly-L-lysine coverslips (Fisher Scientific)
were placed into wells of a 24-well plate, a cell suspen-
sion containing approximately 50,000 cells per well was
added to each well, and the plate was centrifuged at 700
rcf for 5 min. PBS supernatant was removed from the
wells, and the cells attached to the coverslips were fixed
by incubating with 4% PFA for 30 min at RT. After each
step, cells were rinsed (PBS 2–5 min 3X). Cells were
blocked and permeabilized by incubating at RT for
30 min with permeabilization solution and stained with
DEFA and LYZ by incubating with rat anti-mouse Crp1
(Ayabe Lab clone 77-R63, 5 μg/mL, 50X) and rabbit
anti-human Lyz (Dako, RRID: AB_2341230, 200X) pri-
mary antibodies diluted in staining solution overnight at
4 °C. Secondary antibodies Alexa Fluor 647 anti-Rabbit
IgG (RRID: AB_2563202, 400X) and Alexa Fluor 488
anti-Rat IgG (RRID: AB_2563120, 400X) diluted in stain-
ing solution were incubated with the coverslips for 1 h
at RT. Actin was stained with Alexa Fluor 555 Phalloidin
incubated for 20 min at RT, and the nucleus was stained
with DAPI by incubating at RT for 5 mins. Coverslips
were mounted on to slides with Vectashield and imaged
within 48 h using an Applied Precision DeltaVision
Microscope.
Flow cytometry
Cell clusters were isolated from Matrigel as previously
described and resuspended in TrypLE Express at 37 °C
for 20 min to dissociate into single cells. Dissociated
cells were centrifuged at 300 g for 3 min at 4 °C. The
pellet was resuspended in FACS buffer (1% FBS in PBS,
Thermo Fisher Scientific) and strained into a 5 mL filter
cap tube using a 40 μm filter. The cell suspension was
transferred to a flow prep microcentrifuge tube and
centrifuged at 300 rcf for 3 min. Cell pellets were resus-
pended in a Zombie violet dye (BioLegend, 100X) in
FACS buffer for viability staining followed by 1% PFA
fixation for 20 min at RT. Pellets were permeabilized
for 20 min at RT with staining buffer (0.5% Tween-20
in FACS buffer, Sigma), and co-stained with rabbit
anti-human FITC-Lyz (Dako, RRID: AB_578661, 100X)
and rat anti-mouse APC-CD24 (Biolegend, RRID:
AB_2565650, 100X) antibodies diluted in staining
buffer for 45 min at RT. Flow cytometry was per-
formed using a BD LSR II HTS (BD; Koch Institute
Flow Cytometry Core at MIT). Initial settings and laser
voltages were determined with unstained, single chan-
nel stains or secondary-only controls (data not shown).
Flow cytometry data was analyzed using FlowJo v10.7
software. Briefly, gating was performed as seen in
Additional file 3: Figure S1F by removing doubles and
debris, then selecting the BV421– (viable) cell popula-
tion; within this population, gating was based on LYZ–
and CD24– populations.
Lysozyme functional secretion assay
Lysozyme secretion was measured using a Lysozyme
Assay Kit (EnzChek; Thermo Fisher). Briefly, cells sus-
pended in Matrigel in 24-well plates were washed (basal
culture media 3X) and either supplemented with 500 μL
of basal culture media or basal culture media plus
10 μM CCh (Sigma Aldrich) for 24 h at 37 °C. Following
stimulation, culture plates were spun at high speed (>
2000 g) for 5 min at RT to pellet cell debris and loose
Matrigel, and 25 μL of conditioned supernatant was
removed from the top of each well and quantified as per
the manufacturer’s protocol.
Quantification of cell viability, apoptosis, and cytotoxicity
To track proliferation and cell viability, DNA content
was quantified over the course of differentiation and
CCh stimulation using a CyQUANT Cell Proliferation
Assay Kit (Thermo Fisher) as per the manufacturer’s
protocol. Briefly, culture media was aspirated from each
well, and the wells were washed (PBS 3X). Gels were
then mechanically dissociated into PBS, the contents
transferred into a Falcon tube, centrifuged at 300 rcf for
3 min at 4 °C, and the pellet resuspended in PBS to
wash. Tubes were centrifuged at 300 rcf for 5 min at
4 °C, and the pellet was resuspended in 1 mL of assay
working solution (20X cell-lysis buffer, 400X GR dye in
DI water); 200 μL of samples and DNA standards were
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plated in triplicate in a black 96-well plate, shaken for
5 min, then fluorescence was measured on a plate
reader (480 nm/520 nm).
For ENR/ENR + CD co-culture, ISC-enriched orga-
noids (ENR + CV) were differentiated in ENR and ENR
+ CD and isolated as previously described. The cell
pellets were counted and resuspended in basal culture
medium, mixed at 0:100, 25:75, 50:50, 75:25, and 100:0%
ENR:ENR + CD ratios (number of clusters), and plated
as previously described in Matrigel in a 96-well plate at
approximately 50 clusters per well in ENR media. After
24 and 48 h of co-culture, viability versus cytotoxicity
and caspase activation were assessed using ApoTox-Glo
Triplex Assay (Promega) according to the manufac-
turer’s protocol. Briefly, 20 μL of ‘V/C reagent’ (10 μL
each of GF-AFC and bis-AAF-R110 substrates in 2.0 mL
of assay buffer) were added to all wells and mixed by
orbital shaking at 500 rpm for 30 s. After 30 min of
incubation at 37 °C, fluorescence was measured on a
plate reader (400 nm/505 nm for viability and 485 nm/
520 nm for cytotoxicity). Caspase-Glo 3/7 reagent (100 μL)
was then added to all wells and mixed by orbital shaking at
500 rpm for 30 s. After 30 min of incubation at RT, lumi-
nescence was measured on a plate reader.
Bacteria co-culture
For bacteria co-culture, ISC-enriched cells (ENR + CV)
were differentiated in ENR and ENR + CD as previously
described. After 6 days of differentiation, cell clusters
were isolated as previously described. The cell pellet was
resuspended in basal culture medium and plated in sus-
pension in a 96-well plate at approximately 150 clusters
per well. A 1:1 volume of bacteria in respective media
(see ‘Bacterial strains’, above; in exponential growth, as
confirmed by plate reader OD) was added, and bacterial
growth was measured by serial plating (CFU) after a 4 h
incubation. Results for bacteria co-culture were normal-
ized to no cell (bacteria only) controls.
Mass spectrometry proteomics sample preparation,
sequencing, and quantification
Organoid cell pellets were isolated from Matrigel with
mechanical dissociation and washed (cold PBS 5X) to
remove residual extracellular protein. Proteins were ex-
tracted from cell pellets with 8 M urea (Sigma), reduced
with 5 mM DTT (Thermo Fisher Pierce) for 45 min,
alkylated with 10 mM IAA (Sigma) for 45 min in the
dark, and double digested with both Lysyl Endopeptidase
‘LysC’ (Wako) and trypsin (Promega) overnight at RT. A
small aliquot of cellular lysate was removed from each
sample for protein quantification via the Pierce™ BCA
Protein Assay Kit (Pierce). After proteolytic digestion,
the samples were quenched using formic acid to a final
concentration of 1.0% and subsequently desalted on
10 mg OASIS HLB solid phase columns (Waters).
From each condition (n = 8), 50 μg aliquots of the Ng
KD dried tryptic peptides were reconstituted in 100 mM
HEPES at pH 8.0 to a final concentration of 1.0 mg/mL.
The peptides were labeled with TMT-10 isobaric mass
tag reagent according to the manufacturer’s instructions
(ThermoFisher Scientific). The peptides were labeled at
a 1:8 ratio of peptide to TMT reagent, followed by 1 h
incubation at RT with bench-top shaking at 850 rpm.
After incubation, a 1.0 μg aliquot of labeled tryptic
peptide was removed from each labeled condition,
desalted with C18 stage tips, and analyzed via LC-MS/
MS using a Thermo Fisher Q Exactive Plus Hybrid Mass
Spectrometer (QE-Plus) coupled to a Thermo Fisher
EASY-nLC 1000 liquid chromatograph to ensure iso-
baric label incorporation ≥ 95%. An additional 1.0 μg of
labeled tryptic peptide was removed from each channel,
mixed together, desalted on a C18 stage tip, and ana-
lyzed via LC-MS to ensure equal relative protein loads.
During these quality control steps, the labeled peptides
were stored, unquenched, at –80 °C. After validation,
each channel was quenched with a 5% hydroxylamine
solution to a final sample concentration of 0.3% to
quench any unbound isobaric tags. The corresponding
eight channels were mixed together for a total amount
of 400 μg of labeled tryptic peptides. The labeled peptide
mixture was dried down in a speedvac and subsequently
desalted on 30 mg of OASIS HLB solid phase column
(Waters).
The dried, labeled peptides were fractionated into 24
fractions by basic reversed-phase using an Agilent
Zorbax 300 Å, 4.6 mm × 250 mm Extend-C18 column
on an Agilent 1100 Series HPLC instrument (Agilent
Technologies) to decrease sample complexity and in-
crease the dynamic range of detection. Solvent A (2%
acetonitrile, 5 mM ammonium formate, pH 10), and a
non-linear increasing concentration of solvent B (90%
acetonitrile, 5 mM ammonium formate, pH 10) was used
as the mobile phase with a flow rate of 1 mL/min
through the column. A non-linear gradient with increas-
ing percentages of solvent B with four different slopes
was used (0% for 7 min; 0% to 16% in 6 min; 16% to
40% in 60 min; 40% to 44% in 4 min; 44% to 60% in
5 min; 60% for 14 min), and the eluted peptides were
collected in a Whatman polypropylene 2 mL 96-well
plate (Whatman). The 96 fractions were concatenated
down to 25 fractions.
The global proteome (25 fractions) was analyzed by
LC-MS/MS using the same system described above.
Peptides were separated at a flow rate of 200 nL min–1
on a capillary column (Picofrit with a 10-μm tip opening
and 75 μm diameter, New Objective, PF360-75-10-N-5)
packed at the Broad Institute with 20 cm of C18 1.9 μm
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silica beads (1.9 μm ReproSil-Pur C18-AQ medium, Dr.
Maisch GmbH, r119.aq). Injected peptides were sepa-
rated at a flow rate of 200 nL min–1 with a linear 84 min
gradient from 100% solvent A (3% acetonitrile, 0.1% for-
mic acid) to 30% solvent B (90% acetonitrile, 0.1% formic
acid), followed by a linear 9 min gradient from 30% solv-
ent A to 90% solvent B for a total of 110 min. The
QE-Plus instrument was operated in the data-dependent
mode acquiring higher-energy collisional dissociation
tandem mass spectrometry (HCD MS/MS) scans (Reso-
lution = 35,000) for TMT-10 on the 12 most abundant
ions using an MS1 ion target of 3 × 106 ions and an MS2
target of 5 × 104 ions. The maximum ion time used for
the MS/MS scans was 120 ms; the HCD-normalized
collision energy was set to 31; the dynamic exclusion
time was set to 20 s, and the peptide-match preferred
setting was enabled.
Protein and peptide identification and quantification
Peptide spectrum matching and protein identification was
performed using Agilent Technologies SM software pack-
age (developed at the Broad Institute). In SM, FDRs are
calculated at three different levels, namely spectrum, dis-
tinct peptide, and distinct protein. Peptide FDRs are calcu-
lated in SM using essentially the same pseudo-reversal
strategy evaluated by Elias and Gygi [60] and shown to
perform the same as library concatenation. A false distinct
protein ID occurs when all the distinct peptides that group
together to constitute a distinct protein have a deltaFor-
wardReverseScore ≤ 0. We adjusted the settings to provide
peptide FDR of 1–2% and protein FDR of 0–1%. SM also
carries out sophisticated protein grouping using the
methods previously described [61]. Only proteins with
more than two peptides and at least two TMT ratios in
each replicate were counted as being identified and quan-
tified. Additionally, we added the capability to flag poten-
tially unreliable TMT quantification results based on
detection of more than one precursor in the selection win-
dow for MS/MS. The precursor ion flagging was similar
to that recently reported [62], but was carried out post
data acquisition. As an output, SM generates protein and
peptide reports for downstream differential regulation,
pathway, and network analysis. Prior to comprehensive
differential marker, pathway, and network analysis with
the SM-generated protein reports, we ensured that the
data was of high quality and has been properly normal-
ized. The first level of normalization was accomplished by
guaranteeing that an equivalent amount of peptide (50 μg
per) was labeled for each of the 10 TMT channels. Once
the SM reports were generated, we calculated the median
ratios for each of the channels where the denominator of
the ratio was a predetermined TMTchannel signifying the
control condition. The underlying assumption was that
the null distribution is centered at zero in log2 space.
Therefore, in this step of normalization, we normalized
the median log2 ratio for each ratio column so that the
median log2 ratio was zero. To robustly and confidently
detect real differential peptides and proteins in the
TMT-labeled experiment, we performed a moderated t
test [63, 64]. Unlike the standard t test, which is not
robust for small numbers of samples, the moderated t test
uses an empirical Bayes approach that ‘moderates’ vari-
ance estimates for peptides (i.e., shrunk towards a com-
mon value), thereby significantly improving the stability of
variance estimates for individual peptides. The p values re-
ported by the moderated t test were adjusted for multiple
testing using the Benjamini–Hochberg FDR method [64].
Proteome pathway and network analysis
Using the identified and quantified proteins from the
TMT-10 labeling experiment, multiple pathway and net-
work analyses were performed. Sample correlations were
represented as r-values and determined using GraphPad
Prism version 7.0a. To elucidate potential transcriptional
drivers of proteome structure, we performed GSEA
v3.0b2 [37, 38] using the full rank-ordered proteome
against the transcription factor target gene set database
(v5.2 MSigDB) [39], then performed enrichment map
visualization using GSEA-P-based implementation and
Cytoscape v3.4.0 [40, 41], with a moderately conservative
cutoff (p < 0.005 and FDR < 0.075) and an overlap coeffi-
cient of 0.2. To assess the functional and compartmen-
tal functions associated with the ENR + CD-enriched
proteome and ENR-enriched proteome, we used DA-
VID v6.8 [65, 66] and the gene ontology database, look-
ing only at experimentally verified associations within
biological processes, cellular compartments, and mo-
lecular function against a background set of all 8015
quantified proteins.
Single-cell RNA-sequencing
A single-cell suspension was obtained from organoids cul-
tured under ENR + CV, ENR, and ENR +CD conditions
for 6 days as described above. We utilized the Seq-Well
platform for massively parallel scRNA-seq to capture tran-
scriptomes of single cells on barcoded mRNA capture
beads. Full methods on implementation of this platform
are available in Gierahn et al. [28]. In brief, 20,000 cells
from one organoid condition were loaded onto one array
containing 100,000 barcoded mRNA capture beads. The
loaded arrays containing cells and beads were then sealed
using a polycarbonate membrane with a pore size of
0.01 μm, which allows for exchange of buffers but retains
biological molecules confined within each microwell.
Subsequent exchange of buffers allows for cell lysis, tran-
script hybridization, and bead recovery before performing
reverse transcription en masse. Following reverse tran-
scription and exonuclease treatment to remove excess
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primers, PCR amplification was carried out using KAPA
HiFi PCR Mastermix with 2000 beads per 50 μL reaction
volume. Six libraries (totaling 12,000 beads) were then
pooled and purified using Agencourt AMPure XP beads
(Beckman Coulter, A63881) by a 0.6X SPRI followed by a
0.7X SPRI and quantified using Qubit hsDNA Assay
(Thermo Fisher). Libraries were constructed using the
Nextera Tagmentation method on a total of 800 pg of
pooled cDNA library from 12,000 recovered beads. Tag-
mented and amplified sequences were purified at a 0.6X
SPRI ratio yielding library sizes with an average distribu-
tion of 650–750 base pairs in length as determined using
the Agilent hsD1000 Screen Tape System (Agilent Gen-
omics). Arrays were sequenced with an Illumina 75 Cycle
NextSeq500/550v2 kit at a final concentration of 2.8 pM.
The read structure was paired end with Read 1 starting
from a custom read 1 primer containing 20 bases with
a 12 bp cell barcode and 8 bp UMI and Read 2 being
50 bases containing transcript information (Additional
file 10: Table S6 for primers used).
Single-cell RNA-sequencing computational pipelines and
analysis
Read alignment was performed as in Macosko et al. [67].
Briefly, for each NextSeq sequencing run, raw sequen-
cing data was converted to demultiplexed FASTQ files
using bcl2fastq2 based on Nextera N700 indices corre-
sponding to individual samples/arrays. Reads were then
aligned to mm10 genome using the Galaxy portal main-
tained by the Broad Institute for Drop-Seq alignment
using standard settings. Individual reads were tagged
according to the 12 bp barcode sequencing and the 8 bp
UMI contained in Read 1 of each fragment. Following
alignment, reads were binned onto 12 bp cell barcodes
and collapsed by their 8 bp UMI. Digital gene expression
matrices (e.g., cell by gene tables) for each sample were
obtained from quality filtered and mapped reads and
UMI-collapsed data, were deposited in GSE100274, and
were utilized as input into Seurat (https://github.com/
satijalab/seurat) for further analysis [68].
To analyze ENR + CV, ENR, and ENR + CD organoids
together, we merged UMI matrices across all genes de-
tected in any condition and generated a matrix retaining
all cells with at least 1000 UMI detected. This table was
then utilized to setup the Seurat object in which any cell
with at least 400 unique genes was retained and any
gene expressed in at least five cells was retained. The
object was initiated with log-normalization, scaling, and
centering set to True. Before performing dimensionality
reduction, data was subset to include cells with less than
8000 UMI, and a list of 1676 most variable genes was
generated by including genes with an average normal-
ized and scaled expression value greater than 0.14 and
with a dispersion (variance/mean) greater than 0.4. The
total number of ENR + CV, ENR, and ENR + CD cells in-
cluded in the analysis was 985, 2544, and 2382, respect-
ively, with quality metrics for nGene, nUMI, and
percentage of ribosomal and mitochondrial genes re-
ported in Additional file 8: Figure S4. We then per-
formed principal component analysis over the list of
variable genes. For both clustering and t-stochastic
neighbor embedding (tSNE), we utilized the first 12
principal components based on the elbow method, as
upon visual inspection of genes contained within, each
contributing to important biological processes of intes-
tinal cells. We used FindClusters with a resolution of
1.35 and 1000 iterations of tSNE to identify 14 clusters
across the three input samples. To identify genes
which defined each cluster, we performed a ROC test
implemented in Seurat with a threshold set to an
AUC of 0.60.
Transcriptional scoring
To determine the fractional contribution to a cell’s tran-
scriptome of a gene list, we summed the total log(scaled
UMI + 1) expression values for genes within a list of
interest and divided by the total amount of scaled UMI
detected in that cell giving a proportion of a cell’s tran-
scriptome dedicated to producing those genes. From our
proteomic screen, we took a list of upregulated proteins
(249) or downregulated proteins (212) that were de-
tected within our single-cell RNA-sequencing data. To
determine the relationship to in vivo PCs and EECs, we
took reference data from two Seq-Well experiments run
on epithelial cells dissociated from the ileal region of the
small intestine of two C57BL/6 J mice run in separate
experiments. The ileum was first rinsed in 30 mL of ice
cold PBS and allowed to settle. The segment was then
sliced with scissors and transferred to 10 mL of epithe-
lial cell solution (HBSS Ca/Mg-Free 10 mM EDTA,
100 U/mL penicillin, 100 μg/mL streptomycin, 10 mM
HEPES, 2% FCS (ThermoFisher)) freshly supplemented
with 200 μL of 0.5 M EDTA. The epithelial separation
from the underlying lamina propria was performed for
15 min at 37 °C in a rotisserie rack with end-over-end
rotation. The tube was then removed and placed on ice
immediately for 10 min before shaking vigorously 15
times. Visual macroscopic inspection of the tube at this
point yielded visible epithelial sheets, and microscopic
examination confirmed the presence of single-layer
sheets and crypt-villus structures. The epithelial fraction
was spun down at 400 g for 7 min and resuspended in
1 mL of epithelial cell solution before transferring to a
1.5 mL Eppendorf tube to minimize the time spent
centrifuging. Cells were spun down at 800 g for 2 min
and resuspended in TrypLE Express for 5 min in a 37 °C
bath followed by gentle trituration with a P1000 pipette.
Cells were spun down at 800 g for 2 min and
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resuspended in ACK lysis buffer (ThermoFisher) for
3 min on ice to remove red blood cells and dying cells.
Cells were spun down at 800 g for 2 min and resus-
pended in 1 mL of epithelial cell solution and placed on
ice for 3 min before triturating with a P1000 pipette and
filtering into a new Eppendorf through a 40 μm cell
strainer (Falcon/VWR). Cells were spun down at 800 g for
2 min and then resupended in 200 μL of epithelial cell so-
lution and placed on ice for counting. Single-cell RNA-seq
data was then generated as described in the ‘Single-cell
RNA-sequencing’ and ‘Single-cell RNA-sequencing com-
putational pipelines and analysis’ sections in Methods. To
generate PC and EEC signatures, we ran unbiased
SNN-graph based clustering, performed a ROC test, identi-
fied the two mature PC and EEC clusters, and reported all
genes with an AUC above 0.60, using all genes with an
AUC above 0.65 for scoring within each cluster (gene lists
in Additional file 1: Table S1), representing any gene with
enrichment in PCs and EECs. These lists capture genes
which are enriched in PC (Lyz-high) and EECs (Chga-high)
and separate them from the rest of the cells present in in-
testinal epithelium. For pathway analysis, we inspected cu-
rated gene lists deposited in the GSEA platform and used
KEGG-derived Wnt and Reactome-derived Notch and Re-
spiratory Electron Transport Chain signatures (Additional
file 2: Table S2). In vivo transcription factors for PCs and
EECs were determined by matching the PC and EEC signa-
ture gene sets with transcription factors from the Riken
Transcription Factor Database (TFdb - http://genome.g-
sc.riken.jp/TFdb/), and then including only those TFs
which were robustly identified in the proteome dataset.
Quantification and statistical analysis
All statistical analyses were performed using GraphPad
Prism v7.0a, Seurat implemented in RStudio, and Agilent
Technologies Spectrum Mill software package. All graphs
with n > 6 show mean ± SEM, unless otherwise noted,
whereas graphs with n < 6 show mean and individual repli-
cate values. Unpaired two-tail t test and two-way ANOVA
with Dunnett’s multiple comparison test (reported as adj. p
value) were used to assess statistical significance as appro-
priate and, unless otherwise noted, * indicates p < 0.05, ** p
< 0.01 *** p < 0.001, **** p < 0.0001, and ns non-significant.
In each experiment, tissues were isolated from multiple
mice housed in the same facility with each mouse providing
tissue designated as a distinct biological donor: n = 3
donor-averaged values of four technical replicates for data
reported in Fig. 2b; n = 3 donor of two technical replicates
for data reported in Fig. 2e (with exception of day 8, n = 2
donor-averaged values of two technical replicates) and
Additional file 3: Figure S1F; n = 4 (two technical replicates
from two biological donors each) for data reported in
Figs. 2f–h, and Additional file 4: Figure S2; n = 1 biological
donor for in vitro data reported in Figs. 3 and 4 and
Additional file 7: Figure S3 and Additional file 8: Figure S4;
n = 8 single-well replicates from one and five biological
donors for data reported in Fig. 5a, b and c, respectively;
n = 13 co-culture well replicates randomly selected with-
out replacement from four donors for data reported in
Fig. 5d; n = 6 well replicates (two per three biological
donors) in Fig. 5e; n = 3 biological donors in Fig. 6c, and
n = 5 biological donors in Fig. 6d. For scores in single-cell
data, we report effect sizes in addition to statistical signifi-
cance as an additional metric for the magnitude of the
effect observed. The calculation was performed as Cohen’s
d, where effect size d = (Mean1-Mean2)/(SD pooled).
Additional files
Additional file 1: Table S1. Derived gene list of the top defining genes
from in vivo ileal small intestine PCs and EECs captured on the Seq-Well
platform. (XLSX 355 kb)
Additional file 2: Table S2. Reference gene lists used in single-cell
analyses. (XLSX 24 kb)
Additional file 3: Figure S1. Image analysis of cell clusters and flow
cytometry. A Bright-field microscopy after 6 days of ENR + CD culture shows
annular morphology and darkened lumen of cell clusters consistent with
presence of granule-rich cells. B Percentage of total cells that are LYZ+ and
DEFA+ following 6 days of ENR, ENR + CV, and ENR + CD culture (from cell
counting of whole clusters) (n = 3 minimum biological replicates, one-way
ANOVA with multiple comparison test versus ENR, **** adj. p < 0.0001).
C Collapsed z-stack of whole cluster with individual cells highlighted (1–3)
following 6 days of ENR + CD, stained for LYZ and DEFA and counterstained
with DAPI and for actin (phalloidin). (1–3) Normalized mean-area intensity
versus z-axis depth profiles of representative individual LYZ+/DEFA+
co-staining cells. D Representative flow cytometry of ENR and ENR + CD
at 6 days with distinct populations of CD24+ and LYZ+ cells indicative
of phenotypic PCs. E Representative gating for flow cytometry, including
removal of doublets and non-viable cells in final gating. F Percentage of
viable cells (membrane impermeable) over time of ENR versus ENR + CD
culture. (PDF 3217 kb)
Additional file 4: Figure S2. Proteomic pipeline, sample-to-sample
comparison, and insights from the in vitro PC proteome. A Schematic of
proteomic analysis for samples: culture, collection, lysis, reduction and
alkylation, proteolytic digestion, labeling of peptides with isobaric mass tag
reagents (Tandem Mass Tags, TMT10-plex; Thermo), off-line fractionation by
basic reverse phase chromatography, analysis of fractions by LC-MS/MS,
identification of peptides and proteins using Spectrum Mill software
(Agilent), and statistical analysis of the resulting data (moderated t test) to
identify confidently differential proteins. B Proteome sample correlation
between all biological (n = 2) and technical (n = 2/biological) replicates.
C ENR + CD-enriched proteins are well-annotated in the gene ontology
(GO) database and show robust enrichment for functions and compartments
of secretory cells determined by fold enrichment vs. FDR using DAVID. D ENR-
enriched proteins are well annotated in the GO database and show
enrichment for functions and compartments of transcriptionally and
translationally active cells determined by fold enrichment vs. FDR
using DAVID. e GSEA enrichment map of transcription factors linked
to ENR + CD- and ENR-enriched proteins following a moderately
conservative cutoff of p < 0.005, FDR < 0.075, and overlap coefficient
of 0.2. (PDF 483 kb)
Additional file 5: Table S3. Detected and quantified in vitro Proteome.
(XLSX 919 kb)
Additional file 6: Table S4. Complete list of DAVID enrichments.
(XLSX 51 kb)
Additional file 7: Figure S3. Quality metrics for single-cell RNA sequencing.
A Total gene number of cells maintained in analyses with a lower cutoff of
n= 400 unique genes per cell. Total unique molecular identifiers (UMIs) used
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as the basis for cell-by-gene tables collapsed to UMI as input into Seurat with
the lower bound representing n = 400 unique genes and the upper bound
representing 8000 UMIs. Note: Clusters ENR + CV-3, ENR + CV-4, and ENR-1 had
significantly higher levels of genes and UMIs and, intriguingly, were also the
three clusters with the highest levels of Lgr5 (see Fig. 5a), indicating that stem
cells may contain larger contents of RNA, as they are in a biosynthetic state
before differentiation and maturation. B Violin plot of expression
contribution to a cell’s transcriptome of mitochondrial and ribosomal
genes across identified subsets. (PDF 1153 kb)
Additional file 8: Figure S4. Signaling pathways and processes associated
with in vitro PC enrichment (Additional file 9: Table S5 for reference gene
lists). A Violin plot of expression contribution to a cell’s transcriptome of Wnt
pathway genes (Additional file 2: Table S2; activated by CHIR99021) across
clusters as percent of transcriptome. B Violin plot of expression contribution
to a cell’s transcriptome of Notch pathway genes (Additional file 2: Table S2;
inhibited by DAPT) across clusters as percent of transcriptome. C Violin plot
of expression contribution to a cell’s transcriptome of respiratory electron
transport gene set (Additional file 2: Table S2) across clusters as percent of
transcriptome. (PDF 888 kb)
Additional file 9 : Table S5. TaqMan gene expression assays used for
qRT-PCR. (DOCX 13 kb)
Additional file 10: Table S6. SeqWell reverse transcription and library
preparation primers. (DOCX 13 kb)
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